RCM
Revelation Capital Management Portfolio holdings
AUM
$4.26M
This Quarter Return
-39.73%
1 Year Return
-80.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.26M
AUM Growth
+$4.26M
(-40%)
Cap. Flow
-$643K
Cap. Flow
% of AUM
-15.1%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
AKLI
Akili, Inc. Common Stock
AKLI
|
$556K |
Top Sells
| 1 |
Neuropace
NPCE
|
$769K |
| 2 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$430K |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
1
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $3.54M | 83.16% |
1,415,846
| – | – |
|
|
AKLI
2
DELISTED
Akili, Inc. Common Stock
AKLI
| $556K | 13.06% |
+245,912
| New | +$556K |
|
|
3
Neuropace
NPCE
$302M
| $161K | 3.78% |
42,972
-205,155
| -83% | -$769K |
|
|
ACCD
4
DELISTED
Accolade, Inc. Common Stock
ACCD
| – | – |
-58,050
| Closed | -$430K |
|